We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Approves Manufacturing Scale-Up for Pfizer/BioNTech, Moderna Vaccines
EMA Approves Manufacturing Scale-Up for Pfizer/BioNTech, Moderna Vaccines
The European Medicines Agency (EMA) has approved the scale-up of manufacturing of messenger RNA-based COVID-19 vaccines from Pfizer/BioNTech and Moderna to increase supply to the EU, which now appears to be strongly favoring mRNA vaccines over viral vector-based products from AstraZeneca and Johnson & Johnson.